Current Antipsychotics

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Gross, Gerhard (Επιμελητής έκδοσης), Geyer, Mark A. (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2012.
• Σειρά: Handbook of Experimental Pharmacology, 212
• Θέματα: Medicine.; Pharmacy.; Neurosciences.; Pharmacology.; Behavioral sciences.; Proteins.; Neurobiology.; Biomedicine.; Pharmacology/Toxicology.; Receptors.; Behavioral Sciences.

Six decades after the serendipitous discovery of chlorpromazine as an antipsychotic and four decades after the launch of clozapine, the first atypical or second generation antipsychotic, psychopharmacology has arrived at an important crossroad. It is clear that pharmacological research and pharmaceu...

Πίνακας περιεχομένων:

• Preface
• Dopaminergic dysfunction in psychotic disorders.- Role of dopamine D2 receptors for antipsychotic activity
• Dopamine receptor signaling pathways and antipsychotics
• Serotonergic mechanisms as targets for existing and novel antipsychotics
• Antipsychotics in the treatment of psychoses during development
• Weight gain and metabolic disturbances induced by antipsychotic treatments
• Medical needs in the treatment of psychotic disorders
• Antipsychotics in the treatment of bipolar disorders
• Pharmacogenomics of antipsychotics
• Drug interactions and drug monitoting of antipsychotics
• Delivery systems and dosing for antipsychotics
• Imaging as tool to investigate psychoses and antipsychotics
• Biomarkers for antipsychotic therapies
• Behavioral animal models of antipsychotic drug actions. .